I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 7 studies | 41% ± 20% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 20% ± 6% | |
| fibroblast | 6 studies | 29% ± 12% | |
| natural killer cell | 5 studies | 29% ± 15% | |
| erythroblast | 5 studies | 37% ± 7% | |
| astrocyte | 5 studies | 23% ± 3% | |
| GABAergic neuron | 5 studies | 40% ± 19% | |
| neuron | 4 studies | 26% ± 5% | |
| endothelial cell | 4 studies | 26% ± 10% | |
| retinal bipolar neuron | 4 studies | 29% ± 8% | |
| pro-B cell | 4 studies | 29% ± 5% | |
| oligodendrocyte precursor cell | 4 studies | 29% ± 6% | |
| interneuron | 4 studies | 33% ± 19% | |
| hematopoietic precursor cell | 3 studies | 28% ± 15% | |
| conventional dendritic cell | 3 studies | 26% ± 6% | |
| mature NK T cell | 3 studies | 24% ± 5% | |
| granule cell | 3 studies | 22% ± 5% | |
| common myeloid progenitor | 3 studies | 30% ± 11% | |
| rod bipolar cell | 3 studies | 32% ± 5% | |
| erythrocyte | 3 studies | 50% ± 28% | |
| melanocyte | 3 studies | 22% ± 4% |
